Regenerative Medicine Market: By Product Type, By Technology, By Application, By End-user and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Regenerative Medicine Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Biologically Derived Materials, Genetically Engineered Materials, Synthetic Materials, Pharmaceuticals, Others), By Technology (Gene Therapy, Small Molecules and Biologicals, Cell Therapy, Tissue Engineering), By Application (Dermatology, Cardiovascular, Orthopaedic, Oncology, Wound Healing, Neurology, Ophthalmology, Others), By End-user (Hospitals, Clinics, Research Laboratories, Others) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Regenerative Medicine Market size was valued at US$ 9.8 billion in 2023 and is poised to grow at a CAGR of 15.2% from 2024-2030. Regenerative medicines are those, that replace, repair, and regenerate organ and tissues affected due to disease, injury, and the natural aging process. Regenerative medicines have a wide range of applications and are used in neurodegenerative, cardiovascular, orthopedic, and dermatological disorders. Regenerative medicines also include the possibility of growing organs and tissues in the laboratory and implanting them when the body cannot heal itself.

The major biomedical approaches in regenerative medicine are stem cells which have the ability of differentiation and proliferation of cells. An increase in the prevalence of genetic disorders, a rise in funding from public and private sectors for R&D activities in regenerative medicines, an increase in healthcare expenditure, and various products in the pipeline are expected to fuel the regenerative medicines market over the forecast period. Furthermore, technological advancements in stem cell therapy and nanotechnology, the growing need for orthopedic surgeries, and an increase in awareness about regenerative medicines among key stakeholders might propel the market growth over the forecast period.  

Regenerative Medicine Market Key Developments

  • In Oct 2023, Editas Medicine Inc., a clinical-stage genome editing business, announced that EDIT-301, an experimental gene editing medication, has been designated as Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Drug Administration (FDA) for the treatment of severe sickle cell disease (SCD).
  • In May 2024, Andelyn Biosciences, Inc., a premier and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), partnered with the California Institute for Regenerative Medicine's (CIRM), to produce adeno-associated vectors (AAV) therapies using its suspension AAV CuratorTM Platform.

summary download arrow Download Free Sample

Global Regenerative Medicine Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

15.2%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Regenerative Medicines Market Dynamics

Regenerative medicine market is growing at a significant CAGR owing to increase in the prevalence of chronic diseases such as cancer, cardiovascular, and neurological disorders. Increase in the number of organ transplantation and surgical procedures is expected to drive the market growth over the forecast period. Acquisitions, mergers, and collaborations between the companies, and introduction technologically advanced products might increase the competitor’s revenue share in the regenerative medicines market. For instance, in December 2016, Allergan has acquired Lifecell for expanding its product portfolio in a hernia and breast reduction surgeries. Similarly, in June 2014, Aastrom Biosciences acquired the Sanofi's cell therapy and regenerative business segment for strengthening its cell therapy portfolio. Moreover, in March 2016, Hitachi Chemical and Caladrius Biosciences PCT inked an agreement for the manufacturing of regenerative medicine cells.

Global Regenerative Medicine Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 9.8 billion

Market CAGR

15.2%

By Product Type

  • Biologically Derived Materials
  • Genetically Engineered Materials
  • Synthetic Materials
  • Pharmaceuticals
  • Others

By Technology

  • Gene Therapy
  • Small Molecules And Biologicals
  • Cell Therapy
  • Tissue Engineering

By Application

  • Dermatology
  • Cardiovascular
  • Orthopaedic
  • Oncology
  • Wound healing
  • Neurology
  • Ophthalmology
  • Others

By End User

  • Hospitals
  • Clinics
  • Research Laboratories
  • Others

Key Features of the Report

  • The regenerative medicine market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global regenerative medicine market size was valued at US$ 9.8 billion in 2023 and is projected to grow at a CAGR of 15.2% from 2024-2030.

The regenerative medicine market key players are Osiris Therapeutics, Inc. (U.S.) Organogenesis Inc. (U.S.) NuVasive, Inc. (U.S.) Acelity (KCI Concepts) (U.S.) Stryker Corporation (U.S.) Integra LifeSciences (U.S.) Hitachi, Ltd. (Japan) Vericel Corporation (U.S.)

The regenerative medicine possibility of growing organs and tissues in the laboratory and implanting them when the body cannot heal itself.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Regenerative Medicine Market Introduction 
2.1.Global Regenerative Medicine Market  - Taxonomy
2.2.Global Regenerative Medicine Market  - Definitions
2.2.1.Product Type 
2.2.2.Application
2.2.3.Application
2.2.4.End User
2.2.5.Region
3.Global Regenerative Medicine Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Regenerative Medicine Market  By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Biologically Derived Materials
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Genetically Engineered Materials
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Synthetic Materials
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Pharmaceuticals
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Regenerative Medicine Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Gene Therapy
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Small Molecules And Biologicals
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cell Therapy
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Tissue Engineering
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Regenerative Medicine Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Dermatology
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cardiovascular
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Orthopaedic
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Oncology
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Wound healing
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Neurology
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Ophthalmology
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
7.8. Others
7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.8.3. Market Opportunity Analysis 
8.Global Regenerative Medicine Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Clinics
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Research Laboratories
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Regenerative Medicine Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Biologically Derived Materials
10.1.2.Genetically Engineered Materials
10.1.3.Synthetic Materials
10.1.4.Pharmaceuticals
10.1.5.Others
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Gene Therapy
10.2.2.Small Molecules And Biologicals
10.2.3.Cell Therapy
10.2.4.Tissue Engineering
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Dermatology
10.3.2.Cardiovascular
10.3.3.Orthopaedic
10.3.4.Oncology
10.3.5.Wound healing
10.3.6.Neurology
10.3.7.Ophthalmology
10.3.8.Others
10.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Clinics
10.4.3.Research Laboratories
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Biologically Derived Materials
11.1.2.Genetically Engineered Materials
11.1.3.Synthetic Materials
11.1.4.Pharmaceuticals
11.1.5.Others
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Gene Therapy
11.2.2.Small Molecules And Biologicals
11.2.3.Cell Therapy
11.2.4.Tissue Engineering
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Dermatology
11.3.2.Cardiovascular
11.3.3.Orthopaedic
11.3.4.Oncology
11.3.5.Wound healing
11.3.6.Neurology
11.3.7.Ophthalmology
11.3.8.Others
11.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Clinics
11.4.3.Research Laboratories
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Biologically Derived Materials
12.1.2.Genetically Engineered Materials
12.1.3.Synthetic Materials
12.1.4.Pharmaceuticals
12.1.5.Others
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Gene Therapy
12.2.2.Small Molecules And Biologicals
12.2.3.Cell Therapy
12.2.4.Tissue Engineering
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Dermatology
12.3.2.Cardiovascular
12.3.3.Orthopaedic
12.3.4.Oncology
12.3.5.Wound healing
12.3.6.Neurology
12.3.7.Ophthalmology
12.3.8.Others
12.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Clinics
12.4.3.Research Laboratories
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Biologically Derived Materials
13.1.2.Genetically Engineered Materials
13.1.3.Synthetic Materials
13.1.4.Pharmaceuticals
13.1.5.Others
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Gene Therapy
13.2.2.Small Molecules And Biologicals
13.2.3.Cell Therapy
13.2.4.Tissue Engineering
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Dermatology
13.3.2.Cardiovascular
13.3.3.Orthopaedic
13.3.4.Oncology
13.3.5.Wound healing
13.3.6.Neurology
13.3.7.Ophthalmology
13.3.8.Others
13.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Clinics
13.4.3.Research Laboratories
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Biologically Derived Materials
14.1.2.Genetically Engineered Materials
14.1.3.Synthetic Materials
14.1.4.Pharmaceuticals
14.1.5.Others
14.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Gene Therapy
14.2.2.Small Molecules And Biologicals
14.2.3.Cell Therapy
14.2.4.Tissue Engineering
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Dermatology
14.3.2.Cardiovascular
14.3.3.Orthopaedic
14.3.4.Oncology
14.3.5.Wound healing
14.3.6.Neurology
14.3.7.Ophthalmology
14.3.8.Others
14.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Clinics
14.4.3.Research Laboratories
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Osiris Therapeutics, Inc. (U.S.)
15.2.2.Organogenesis Inc. (U.S.)
15.2.3.NuVasive, Inc. (U.S.)
15.2.4.Acelity (KCI Concepts) (U.S.)
15.2.5.Stryker Corporation (U.S.)
15.2.6.Integra LifeSciences (U.S.)
15.2.7.Hitachi, Ltd. (Japan)
15.2.8.Vericel Corporation (U.S.)
15.2.9.C.R. Bard (U.S.)
15.2.10.Allergan (Ireland)
15.2.11.Caladrius Biosciences (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Osiris Therapeutics, Inc. (U.S.)
  • Organogenesis Inc. (U.S.)
  • NuVasive, Inc. (U.S.)
  • Acelity (KCI Concepts) (U.S.)
  • Stryker Corporation (U.S.)
  • Integra LifeSciences (U.S.)
  • Hitachi, Ltd. (Japan)
  • Vericel Corporation (U.S.)
  • C.R. Bard (U.S.)
  • Allergan (Ireland)
  • Caladrius Biosciences (U.S.)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market